{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:37:11Z","timestamp":1793223431356,"version":"4.5.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.bcp.2020.114363","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T12:34:06Z","timestamp":1607517246000},"page":"114363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["PGE2 receptors in detrusor muscle: Drugging the undruggable for urgency"],"prefix":"10.1016","volume":"184","author":[{"given":"Ruida","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2020.114363_b0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00192-009-0976-9","article-title":"An International Urogynecological Assocation (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction","volume":"21","author":"Haylen","year":"2010","journal-title":"Int. Urogynecol. J."},{"issue":"3","key":"10.1016\/j.bcp.2020.114363_b0010","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/JU.0000000000000309","article-title":"Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA\/SUFU Guideline Amendment 2019","volume":"202","author":"Lightner","year":"2019","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.bcp.2020.114363_b0015","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bcp.2020.114363_b0020","doi-asserted-by":"crossref","unstructured":"M.L. Ganz, A.M. Smalarz, T.L. Krupski, J.T. Anger, J.C. Hu, K.U. Wittrup-Jensen, C.L. Pashos, Economic costs of overactive bladder in the United States, Urology 75(3) (2010) 526-32, 532 e1-18.","DOI":"10.1016\/j.urology.2009.06.096"},{"issue":"7","key":"10.1016\/j.bcp.2020.114363_b0025","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/bph.14921","article-title":"beta3 Adrenoceptor-induced cholinergic inhibition in human and rat urinary bladders involves the exchange protein directly activated by cyclic AMP 1 favoring adenosine release","volume":"177","author":"Silva","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2020.114363_b0030","doi-asserted-by":"crossref","first-page":"F388","DOI":"10.1152\/ajprenal.00392.2016","article-title":"Inhibition of cholinergic neurotransmission by beta3-adrenoceptors depends on adenosine release and A1-receptor activation in human and rat urinary bladders","volume":"313","author":"Silva","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.bcp.2020.114363_b0035","first-page":"79","article-title":"OnabotulinumtoxinA for the treatment of overactive bladder","volume":"6","author":"Cox","year":"2014","journal-title":"Res. Reports in Urol."},{"key":"10.1016\/j.bcp.2020.114363_b0040","unstructured":"M. Drake, Overactive Bladder, in: L.R.K. Alan J. Wein, Alan W. Partin, Craig A. Peters (Ed.), Campbell-Walsh Urology, Elsevier, Philadelphia, PA, U.S., 2015, p. 1799."},{"issue":"1","key":"10.1016\/j.bcp.2020.114363_b0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ogc.2015.10.002","article-title":"Overactive Bladder","volume":"43","author":"White","year":"2016","journal-title":"Obstet. Gynecol. Clin. North Am."},{"issue":"6","key":"10.1016\/j.bcp.2020.114363_b0050","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.eururo.2008.02.037","article-title":"Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity","volume":"53","author":"Apostolidis","year":"2008","journal-title":"Eur. Urol."},{"issue":"3","key":"10.1016\/j.bcp.2020.114363_b0055","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11255-009-9647-5","article-title":"Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study","volume":"42","author":"Tyagi","year":"2010","journal-title":"Int. Urol. Nephrol."},{"issue":"10","key":"10.1016\/j.bcp.2020.114363_b0060","doi-asserted-by":"crossref","first-page":"568","DOI":"10.5603\/GP.a2017.0102","article-title":"Novel biomarkers of overactive bladder syndrome","volume":"88","author":"Wrobel","year":"2017","journal-title":"Ginekol. Pol."},{"issue":"7","key":"10.1016\/j.bcp.2020.114363_b0065","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00192-017-3547-5","article-title":"Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder","volume":"29","author":"Furuta","year":"2018","journal-title":"Int. Urogynecol. J."},{"issue":"4","key":"10.1016\/j.bcp.2020.114363_b0070","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1124\/pr.56.4.4","article-title":"Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence","volume":"56","author":"Andersson","year":"2004","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2020.114363_b0075","first-page":"F129","article-title":"Obstruction stimulates COX-2 expression in bladder smooth muscle cells via increased mechanical stretch","volume":"276","author":"Park","year":"1999","journal-title":"Am. J. Physiol."},{"issue":"2","key":"10.1016\/j.bcp.2020.114363_b0080","doi-asserted-by":"crossref","first-page":"R574","DOI":"10.1152\/ajpregu.00465.2002","article-title":"COX-2 and prostanoid expression in micturition pathways after cyclophosphamide-induced cystitis in the rat","volume":"284","author":"Hu","year":"2003","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"5","key":"10.1016\/j.bcp.2020.114363_b0085","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0022-5347(05)00992-4","article-title":"Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder","volume":"175","author":"Kim","year":"2006","journal-title":"J. Urol."},{"issue":"10","key":"10.1016\/j.bcp.2020.114363_b0090","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1442-2042.2005.01140.x","article-title":"Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom","volume":"12","author":"Kim","year":"2005","journal-title":"Int. J. Urol."},{"issue":"5","key":"10.1016\/j.bcp.2020.114363_b0095","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF00300786","article-title":"Comparison of the mode of action of prostaglandin E2 (PGE2) and sulprostone, a PGE2-derivative, on the lower urinary tract in healthy women. A urodynamic study","volume":"18","author":"Schussler","year":"1990","journal-title":"Urol. Res."},{"issue":"4","key":"10.1016\/j.bcp.2020.114363_b0100","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.juro.2006.11.070","article-title":"Urodynamic effects of a novel EP(1) receptor antagonist in normal rats and rats with bladder outlet obstruction","volume":"177","author":"Lee","year":"2007","journal-title":"J. Urol."},{"issue":"5","key":"10.1016\/j.bcp.2020.114363_b0105","doi-asserted-by":"crossref","first-page":"F1169","DOI":"10.1152\/ajprenal.00270.2017","article-title":"OAB without an overactive bladder in the acute prostaglandin E2 rat model","volume":"313","author":"Hokanson","year":"2017","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bcp.2020.114363_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101682","article-title":"G protein-coupled receptors in acquired epilepsy: Druggability and translatability","volume":"183","author":"Yu","year":"2019","journal-title":"Prog. Neurobiol."},{"issue":"9B","key":"10.1016\/j.bcp.2020.114363_b0115","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1111\/j.1582-4934.2008.00475.x","article-title":"The localization of cyclo-oxygenase immuno-reactivity (COX I-IR) to the urothelium and to interstitial cells in the bladder wall","volume":"13","author":"de Jongh","year":"2009","journal-title":"J. Cell Mol. Med."},{"issue":"4","key":"10.1016\/j.bcp.2020.114363_b0120","first-page":"F538","article-title":"Cyclooxygenase-2 is expressed in bladder during fetal development and stimulated by outlet obstruction","volume":"273","author":"Park","year":"1997","journal-title":"Am. J. Physiol."},{"issue":"Suppl","key":"10.1016\/j.bcp.2020.114363_b0125","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1194\/jlr.R800042-JLR200","article-title":"Cyclooxygenases: structural and functional insights","volume":"50","author":"Rouzer","year":"2009","journal-title":"J. Lipid Res."},{"issue":"8","key":"10.1016\/j.bcp.2020.114363_b0130","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/nau.21153","article-title":"The effect of intravesical acetylsalicylic acid instillation on tissue prostaglandin levels after partial bladder outlet obstruction in rabbits","volume":"30","author":"Kibar","year":"2011","journal-title":"Neurourol. Urodyn."},{"issue":"2","key":"10.1016\/j.bcp.2020.114363_b0135","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.bjp.0703309","article-title":"Pharmacological evaluation of the role of cyclooxygenase isoenzymes on the micturition reflex following experimental cystitis in rats","volume":"130","author":"Lecci","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2020.114363_b0140","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1464-410X.2006.06003.x","article-title":"Effect of cyclooxygenase inhibitors on the micturition reflex in rats: correlation with inhibition of cyclooxygenase isozymes","volume":"97","author":"Angelico","year":"2006","journal-title":"BJU Int."},{"issue":"3","key":"10.1016\/j.bcp.2020.114363_b0145","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0022-5347(17)55955-8","article-title":"A comparison between bromocriptine and indomethacin in the treatment of detrusor instability","volume":"123","author":"Cardozo","year":"1980","journal-title":"J. Urol."},{"issue":"4","key":"10.1016\/j.bcp.2020.114363_b0150","first-page":"423","article-title":"Intravesically administered ketoprofen in treatment of detrusor instability: cross-over study","volume":"41","author":"Sprem","year":"2000","journal-title":"Croat. Med. J."},{"issue":"1","key":"10.1016\/j.bcp.2020.114363_b0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI27291","article-title":"Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities","volume":"116","author":"Grosser","year":"2006","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.bcp.2020.114363_b0160","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.tips.2013.05.003","article-title":"Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection","volume":"34","author":"Jiang","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2020.114363_b0165","article-title":"Small molecules targeting cyclooxygenase\/prostanoid cascade in experimental brain ischemia: Do they translate?","author":"Jiang","year":"2020","journal-title":"Med. Res. Rev. n\/a(n\/a)"},{"issue":"2","key":"10.1016\/j.bcp.2020.114363_b0170","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.trecan.2016.12.002","article-title":"Prostaglandin E2 Signaling: Alternative Target for Glioblastoma?","volume":"3","author":"Jiang","year":"2017","journal-title":"Trends Cancer"},{"issue":"3","key":"10.1016\/j.bcp.2020.114363_b0175","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1124\/pr.110.003517","article-title":"International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress","volume":"63","author":"Woodward","year":"2011","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.bcp.2020.114363_b0180","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrurol.2012.33","article-title":"The role of prostanoids in urinary bladder physiology","volume":"9","author":"Rahnama'i","year":"2012","journal-title":"Nat. Rev. Urol."},{"issue":"24","key":"10.1016\/j.bcp.2020.114363_b0185","doi-asserted-by":"crossref","first-page":"22907","DOI":"10.1074\/jbc.M500130200","article-title":"Prostaglandin E2 stimulates fibronectin expression through EP1 receptor, phospholipase C, protein kinase Calpha, and c-Src pathway in primary cultured rat osteoblasts","volume":"280","author":"Tang","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2020.114363_b0190","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1161\/01.RES.87.12.1095","article-title":"Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C","volume":"87","author":"Kamp","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2020.114363_b0195","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejphar.2014.05.042","article-title":"Prostaglandin E2 excitatory effects on guinea pig urinary bladder smooth muscle: a novel regulatory mechanism mediated by large-conductance voltage- and Ca2+-activated K+ channels","volume":"738","author":"Parajuli","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114363_b0200","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrurol.2011.194","article-title":"Role of potassium ion channels in detrusor smooth muscle function and dysfunction","volume":"9","author":"Petkov","year":"2011","journal-title":"Nat. Rev. Urol."},{"issue":"2","key":"10.1016\/j.bcp.2020.114363_b0205","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/nau.22809","article-title":"Do we need to know more about the effects of hormones on lower urinary tract dysfunction? ICI-RS 2014","volume":"35","author":"Hanna-Mitchell","year":"2016","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.bcp.2020.114363_b0210","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fphys.2014.00289","article-title":"Functional insights into modulation of BKCa channel activity to alter myometrial contractility","volume":"5","author":"Lorca","year":"2014","journal-title":"Front. Physiol."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2020.114363_b0215","first-page":"2","article-title":"Gender differences in overactive bladder","volume":"23","author":"Eapen","year":"2016","journal-title":"Can J Urol"},{"issue":"3","key":"10.1016\/j.bcp.2020.114363_b0220","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.steroids.2007.10.010","article-title":"Differential effects of estrogen and progesterone on potassium channels expressed in Xenopus oocytes","volume":"73","author":"Wong","year":"2008","journal-title":"Steroids"},{"issue":"9","key":"10.1016\/j.bcp.2020.114363_b0225","doi-asserted-by":"crossref","first-page":"R544","DOI":"10.1016\/S0960-9822(06)00277-6","article-title":"Calcium signalling: how do IP3 receptors work?","volume":"7","author":"Dawson","year":"1997","journal-title":"Curr. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2020.114363_b0230","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/cm.20471","article-title":"MLCK-independent phosphorylation of MLC20 and its regulation by MAP kinase pathway in human bladder smooth muscle cells","volume":"68","author":"Deng","year":"2011","journal-title":"Cytoskeleton (Hoboken)"},{"key":"10.1016\/j.bcp.2020.114363_b0235","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jchemneu.2015.03.001","article-title":"Evidence for prostaglandin E2 receptor expression in the intramural ganglia of the guinea pig urinary bladder","volume":"64\u201365","author":"Rahnama'i","year":"2015","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.bcp.2020.114363_b0240","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ejphar.2015.11.030","article-title":"Prostanoid receptors mediating contraction in rat, macaque and human bladder smooth muscle in vitro","volume":"769","author":"Root","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2020.114363_b0245","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/01.ju.0000134186.58854.2c","article-title":"Detrusor responses to prostaglandin E2 and bladder outlet obstruction in wild-type and Ep1 receptor knockout mice","volume":"172","author":"Schroder","year":"2004","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.bcp.2020.114363_b0250","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2220\/biomedres.27.49","article-title":"Prostaglandin facilitates afferent nerve activity via EP1 receptors during urinary bladder inflammation in rats","volume":"27","author":"Ikeda","year":"2006","journal-title":"Biomed. Res."},{"issue":"2","key":"10.1016\/j.bcp.2020.114363_b0255","doi-asserted-by":"crossref","DOI":"10.14440\/bladder.2016.72","article-title":"Ex vivo modulation of muscarinically induced contractions by PGE2 and an EP1 receptor antagonist in the guinea pig urinary bladder","volume":"3","author":"Hohnen","year":"2016","journal-title":"Bladder"},{"issue":"1","key":"10.1016\/j.bcp.2020.114363_b0260","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.juro.2013.08.082","article-title":"Phase II study on the efficacy and safety of the EP1 receptor antagonist ONO-8539 for nonneurogenic overactive bladder syndrome","volume":"191","author":"Chapple","year":"2014","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114363_b0265","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bju.13180","article-title":"Actions of cAMP on calcium sensitization in human detrusor smooth muscle contraction","volume":"117","author":"Hayashi","year":"2016","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.bcp.2020.114363_b0270","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00018-011-0815-2","article-title":"Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle","volume":"69","author":"Morgado","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.bcp.2020.114363_b0275","doi-asserted-by":"crossref","first-page":"C299","DOI":"10.1152\/ajpcell.00065.2013","article-title":"Overactive bladder mediated by accelerated Ca2+ influx mode of Na+\/Ca2+ exchanger in smooth muscle","volume":"305","author":"Yamamura","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"6","key":"10.1016\/j.bcp.2020.114363_b0280","doi-asserted-by":"crossref","first-page":"R571","DOI":"10.1152\/ajpregu.00142.2014","article-title":"Central role of the BK channel in urinary bladder smooth muscle physiology and pathophysiology","volume":"307","author":"Petkov","year":"2014","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"3","key":"10.1016\/j.bcp.2020.114363_b0285","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.juro.2009.11.004","article-title":"Prostaglandin receptor EP1 and EP2 site in guinea pig bladder urothelium and lamina propria","volume":"183","author":"Rahnama'i","year":"2010","journal-title":"J. Urol."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2020.114363_b0290","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.prostaglandins.2012.08.005","article-title":"The distribution of the prostaglandin E receptor type 2 (EP2) in the detrusor of the guinea pig","volume":"99","author":"Rahnama'i","year":"2012","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"2","key":"10.1016\/j.bcp.2020.114363_b0295","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.juro.2016.02.064","article-title":"Promising Effects of a Novel EP2 and EP3 Receptor Dual Agonist, ONO-8055, on Neurogenic Underactive Bladder in a Rat Lumbar Canal Stenosis Model","volume":"196","author":"Sekido","year":"2016","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114363_b0300","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/luts.12284","article-title":"Further characterization of a novel EP2 and EP3 receptor dual agonist, ONO-8055, on lower urinary tract function in normal and lumbar canal stenosis rats","volume":"12","author":"Sekido","year":"2020","journal-title":"Low Urin Tract Symptoms"},{"issue":"2","key":"10.1016\/j.bcp.2020.114363_b0305","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/luts.12166","article-title":"Effects of an EP2 and EP3 Receptor Dual Agonist, ONO-8055, on a Radical Hysterectomy-Induced Underactive Bladder Model in Monkeys","volume":"10","author":"Matsuya","year":"2018","journal-title":"Low Urin Tract Symptoms"},{"issue":"1","key":"10.1016\/j.bcp.2020.114363_b0310","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bmc.2017.11.035","article-title":"Synthesis and evaluation of a potent, well-balanced EP2\/EP3 dual agonist","volume":"26","author":"Kinoshita","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2020.114363_b0315","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1021\/cr200010h","article-title":"Prostanoid receptors","volume":"111","author":"Hirata","year":"2011","journal-title":"Chem. Rev."},{"issue":"2","key":"10.1016\/j.bcp.2020.114363_b0320","doi-asserted-by":"crossref","first-page":"F507","DOI":"10.1152\/ajprenal.00054.2008","article-title":"Enhanced bladder capacity and reduced prostaglandin E2-mediated bladder hyperactivity in EP3 receptor knockout mice","volume":"295","author":"McCafferty","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10.1016\/j.bcp.2020.114363_b0325","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.bbrc.2017.01.131","article-title":"EP3 activation facilitates bladder excitability via HCN channels on ICCs","volume":"485","author":"Wu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2020.114363_b0330","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/jnc.12624","article-title":"Activation of rhodopsin gene transcription in cultured retinal precursors of chicken embryo: role of Ca(2+) signaling and hyperpolarization-activated cation channels","volume":"129","author":"Bernard","year":"2014","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.bcp.2020.114363_b0335","doi-asserted-by":"crossref","first-page":"F585","DOI":"10.1152\/ajprenal.90273.2008","article-title":"An excitatory role for peripheral EP3 receptors in bladder afferent function","volume":"295","author":"Su","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114363_b0340","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1476-5381.2009.00275.x","article-title":"Dual modulation of urinary bladder activity and urine flow by prostanoid EP3 receptors in the conscious rat","volume":"158","author":"Jugus","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2020.114363_b0345","doi-asserted-by":"crossref","first-page":"F1656","DOI":"10.1152\/ajprenal.00271.2013","article-title":"Effects of PGE2 EP3\/EP4 receptors on bladder dysfunction in mice with experimental autoimmune encephalomyelitis","volume":"305","author":"Xue","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"6","key":"10.1016\/j.bcp.2020.114363_b0350","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.juro.2011.07.087","article-title":"Bladder outlet obstruction induced expression of prostaglandin E2 receptor subtype EP4 in the rat bladder: a possible counteractive mechanism against detrusor overactivity","volume":"186","author":"Beppu","year":"2011","journal-title":"J. Urol."},{"issue":"11","key":"10.1016\/j.bcp.2020.114363_b0355","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/j.1464-410X.2010.09260.x","article-title":"Expression of E-series prostaglandin (EP) receptors and urodynamic effects of an EP4 receptor antagonist on cyclophosphamide-induced overactive bladder in rats","volume":"106","author":"Chuang","year":"2010","journal-title":"BJU Int."},{"issue":"10","key":"10.1016\/j.bcp.2020.114363_b0360","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1464-410X.2012.11096.x","article-title":"Mechanisms and urodynamic effects of a potent and selective EP4 receptor antagonist, MF191, on cyclophosphamide and prostaglandin E2-induced bladder overactivity in rats","volume":"110","author":"Chuang","year":"2012","journal-title":"BJU Int."},{"issue":"5","key":"10.1016\/j.bcp.2020.114363_b0365","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/bju.14845","article-title":"The role of prostaglandin and E series prostaglandin receptor type 4 receptors in the development of bladder overactivity in a rat model of chemically induced prostatic inflammation","volume":"124","author":"Mizoguchi","year":"2019","journal-title":"BJU Int."},{"issue":"1","key":"10.1016\/j.bcp.2020.114363_b0370","first-page":"13","article-title":"The role of prostanoids in the urinary bladder function and a potential use of prostanoid-targeting pharmacological agents in bladder overactivity treatment","volume":"72","author":"Dobrek \u0141ukasz","year":"2015","journal-title":"Acta Pol. Pharm."},{"issue":"1","key":"10.1016\/j.bcp.2020.114363_b0375","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drudis.2016.08.003","article-title":"Structural features of subtype-selective EP receptor modulators","volume":"22","author":"Markovic","year":"2017","journal-title":"Drug Discovery Today"},{"issue":"8","key":"10.1016\/j.bcp.2020.114363_b0380","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1073\/pnas.1120195109","article-title":"Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2","volume":"109","author":"Jiang","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.bcp.2020.114363_b0385","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1021\/ml400112h","article-title":"Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists","volume":"4","author":"Ganesh","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.bcp.2020.114363_b0390","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1073\/pnas.0909310107","article-title":"Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor","volume":"107","author":"Jiang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.bcp.2020.114363_b0395","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1021\/acschemneuro.7b00486","article-title":"Discovery of 2-Piperidinyl Phenyl Benzamides and Trisubstituted Pyrimidines as Positive Allosteric Modulators of the Prostaglandin Receptor EP2","volume":"9","author":"Jiang","year":"2018","journal-title":"ACS Chem. Neurosci."},{"issue":"10","key":"10.1016\/j.bcp.2020.114363_b0400","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1021\/jm5000672","article-title":"Lead optimization studies of cinnamic amide EP2 antagonists","volume":"57","author":"Ganesh","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2020.114363_b0405","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ejmech.2014.05.076","article-title":"Development of second generation EP2 antagonists with high selectivity","volume":"82","author":"Ganesh","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2020.114363_b0410","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.nbd.2014.12.032","article-title":"Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus","volume":"76","author":"Jiang","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.bcp.2020.114363_b0415","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1586\/14737175.2016.1134322","article-title":"Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus","volume":"16","author":"Du","year":"2016","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bcp.2020.114363_b0420","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuropharm.2019.02.011","article-title":"Suppressing pro-inflammatory prostaglandin signaling attenuates excitotoxicity-associated neuronal inflammation and injury","volume":"149","author":"Jiang","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2020.114363_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107504","article-title":"Targeting prostaglandin receptor EP2 for adjunctive treatment of status epilepticus","volume":"209","author":"Nagib","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2020.114363_b0430","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/epi4.12409","article-title":"COX-2\/PGE2 axis regulates hippocampal BDNF\/TrkB signaling via EP2 receptor after prolonged seizures","volume":"5","author":"Yu","year":"2020","journal-title":"Epilepsia Open"},{"issue":"1","key":"10.1016\/j.bcp.2020.114363_b0435","doi-asserted-by":"crossref","first-page":"9459","DOI":"10.1038\/s41598-017-09528-z","article-title":"Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype","volume":"7","author":"Kang","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2020.114363_b0440","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12974-020-01993-0","article-title":"Cyclooxygenase-1 mediates neuroinflammation and neurotoxicity in a mouse model of retinitis pigmentosa","volume":"17","author":"Yang","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.bcp.2020.114363_b0445","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/mol.115.098202","article-title":"EP2 Receptor Signaling Regulates Microglia Death","volume":"88","author":"Fu","year":"2015","journal-title":"Mol. Pharmacol."},{"issue":"13","key":"10.1016\/j.bcp.2020.114363_b0450","doi-asserted-by":"crossref","first-page":"9293","DOI":"10.1074\/jbc.M113.455816","article-title":"EP2 receptor signaling pathways regulate classical activation of microglia","volume":"288","author":"Quan","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2020.114363_b0455","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1124\/jpet.112.200444","article-title":"Role of prostaglandin receptor EP2 in the regulations of cancer cell proliferation, invasion, and inflammation","volume":"344","author":"Jiang","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.bcp.2020.114363_b0460","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1111\/bph.14622","article-title":"Small-molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase-associated malignant glioma growth","volume":"176","author":"Qiu","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114363_b0465","unstructured":"J. Jiang, Methods and compositions for the treatment of gliomas, University of Cincinnati, US patent 10758516, 2020."},{"issue":"1","key":"10.1016\/j.bcp.2020.114363_b0470","doi-asserted-by":"crossref","first-page":"44169","DOI":"10.1038\/srep44169","article-title":"EP2 receptor antagonism reduces peripheral and central hyperalgesia in a preclinical mouse model of endometriosis","volume":"7","author":"Greaves","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bcp.2020.114363_b0475","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1021\/acsptsci.0c00040","article-title":"Inhibiting the PGE2 Receptor EP2 Mitigates Excitotoxicity and Ischemic Injury","volume":"3","author":"Li","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.bcp.2020.114363_b0480","article-title":"Prostaglandin E receptors as targets for ischemic stroke: Novel evidence and molecular mechanisms of efficacy","volume":"105238","author":"Li","year":"2020","journal-title":"Pharmacol. Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220305992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220305992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:19:00Z","timestamp":1757769540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220305992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":96,"alternative-id":["S0006295220305992"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114363","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PGE2 receptors in detrusor muscle: Drugging the undruggable for urgency","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114363","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114363"}}